ORLANDO, Fla., Nov. 1 /PRNewswire-FirstCall/ -- Telzuit Medical Technologies, Inc. announced that it has achieved initial sales of the STATPATCH System of $10,000 to a Central Florida medical practice. The medical practice has begun to use the patch on patients. Telzuit is closely monitoring this use and is utilizing this information to make refinements to the STATPATCH system. Once the Company is satisfied with the enhancements to the product it will undertake a broader release of the product.
Warren Stowell, CEO of Telzuit, stated that he was pleased with the initial release of the product and looks forward to a broader distribution in the future. He further noted that Telzuit has additional work to complete on the STATPATCH System, but that the current release of the product provides the same information to the physician as a traditional Holter monitor.
About Telzuit Medical Technologies, Inc.
Telzuit Medical technologies, Inc. is dedicated to providing advanced mobile medicine to patients. The STATPATCH System is a full 12-lead, completely wireless Holter monitor. The STATPATCH System has been approved by the FDA under a 510-K filing. Telzuit also operates two walk-in medical clinics in the Orlando area and provides ultrasound medical imaging services to physicians in Central Florida through six mobile imaging units. Telzuit is based in Orlando. For more information about Telzuit, its business model and its products, please visit the Company’s web site: http/www.telzuit.com.
Forward Looking Statements: Except for factual statements made herein, the information contained in this press release consists of forward looking statements that involve risks and uncertainties, including the effect of changing economic conditions, competition within the health products industry, customer acceptance of products, and other risks and uncertainties. Such forward-looking statements are not guarantees of performance, and Telzuit results could differ materially from those contained in such statements. These forward-looking statements speak only as of the date of this release, and Telzuit undertakes no obligation to publicly update any forward-looking statements to reflect new information, events or circumstances after the date of this release.
Contact: Jerry Balter Chief Financial Officer Telzuit Medical Technologies, Inc 407-354-1222
Telzuit Medical Technologies, Inc.
CONTACT: Jerry Balter, Chief Financial Officer of Telzuit MedicalTechnologies, Inc., +1-407-354-1222
Web site: http://www.telzuit.com/